October 2019 FDA Recall Drug by New Vitalis Pharmacy Llc Dba New Vitalis Pharmacy
D-0523-2020 - Lack of sterility assurance.

This Class II drug recall was voluntarily initiated by New Vitalis Pharmacy Llc Dba New Vitalis Pharmacy on October 1, 2019 for the product Drug. The FDA reported the reason for recall as lack of sterility assurance.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0523-2020

Reason for Recall
Lack of sterility assurance.
Initiated
10-01-2019
Reported
12-04-2019
Quantity
2981.62 mL

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
New Vitalis Pharmacy LLC dba New Vitalis Pharmacy
Distributed Nationwide in the USA
Testosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil Injection Solution, 10 mL per vial, New Vitalis Pharmacy

Batch or Lot Expiration Information

Lot# Lot, expiry: AL-07232019@99, exp 9-23-2019; AL-07312019@99, exp 9-30-2019; AL-08132019@99, exp 10-13-2019; AL-08272019@901, exp 10-27-2019; AL-08282019@909, exp 10-28-2019; Al-09032019@903, exp 11-3-2019